Aprepitant - PDFSEARCH.IO - Document Search Engine

Aprepitant
Results: 58

#	Item
31	PRODUCT MONOGRAPH EMEND® aprepitant capsules 80 and 125 mg Add to Reading List Source URL: www.merck.ca Language: English - Date: 2014-09-29 16:29:49 Organic chemistry Oncology Ketones Organofluorides Triazoles Aprepitant Chemotherapy-induced nausea and vomiting Chemotherapy Adverse effect Medicine Chemistry Antiemetics
32	The n e w e ng l a n d j o u r na l of Add to Reading List Source URL: www.motilitysociety.org Language: English - Date: 2010-01-25 16:01:34 Antiemetics Chemotherapy-induced nausea and vomiting Aprepitant Dolasetron 5-HT3 antagonist NK1 receptor antagonist Ondansetron Palonosetron Granisetron Chemistry Medicine Organic chemistry
33	IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION EMEND® aprepitant capsules This leaflet is part III of a three-part “Product Monograph” Add to Reading List Source URL: www.merck.ca Language: English - Date: 2014-09-29 16:21:44 Patient safety Organofluorides Dow Jones Industrial Average Merck & Co. Readington New Jersey Aprepitant Adverse effect Prescription medication Pharmaceutical drug Medicine Pharmacology Health
34	MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Antiemetics A. Add to Reading List Source URL: www.dpw.state.pa.us Language: English - Date: 2013-11-08 17:44:24 Nabilone Ondansetron Promethazine Gastroenteritis Vomiting 5-HT3 antagonist Aprepitant Nausea Chemotherapy Medicine Antiemetics Chemotherapy-induced nausea and vomiting
35	MONOGRAPHIE DE PRODUIT EMEND® gélules d’aprépitant 80 mg et 125 mg Antagoniste des récepteurs NK1 de la neurokinine Add to Reading List Source URL: www.merck.ca Language: French - Date: 2014-09-23 00:54:53
36	IMPORTANT – VEUILLEZ LIRE ATTENTIVEMENT PARTIE III : RENSEIGNEMENTS POUR LE CONSOMMATEUR EMEND® gélules d’aprépitant Le présent dépliant constitue la troisième et dernière Add to Reading List Source URL: www.merck.ca Language: French - Date: 2014-09-23 00:28:52
37	Oral Antiemetic Agents (except Cesamet and Emend) (See separate Summary Sheets for Cesamet and Emend Coverage Policies) Covered medications Dolasetron (Anzemet), Granisetron (Kytril, Granisol™ oral solution Add to Reading List Source URL: statehealthplan.state.nc.us Language: English - Date: 2013-10-03 14:58:45 Medicine 5-HT3 antagonist Granisetron Ondansetron Dolasetron Serotonin Aprepitant Hyperemesis gravidarum Chemotherapy-induced nausea and vomiting Chemistry Antiemetics Organic chemistry
38	Emend (See other Summary Sheets for other Antiemetic Agents Coverage Policies) Covered Medication Aprepitant (Emend ) What it does and how it is used Add to Reading List Source URL: statehealthplan.state.nc.us Language: English - Date: 2013-10-03 14:58:44 Organic chemistry Aprepitant Dolasetron Postoperative nausea and vomiting Chemotherapy Ondansetron Granisetron Vomiting Chemotherapy-induced nausea and vomiting Medicine Chemistry Antiemetics
39	Prior Authorization Request Form for Anti-Nausea products-Emend/Kytril/Zofran Add to Reading List Source URL: www.mainecarepdl.org Language: English - Date: 2012-04-02 14:37:56 Organic chemistry Chemotherapy-induced nausea and vomiting 5-HT3 antagonist Nausea Granisetron Ondansetron Aprepitant Antiemetics Medicine Chemistry
40	CMS Manual System Department of Health & Human Services (DHHS) Pub[removed]Medicare Claims Processing Add to Reading List Source URL: www.cms.gov Language: English - Date: 2014-04-15 16:12:07 Antiemetics Oncology Federal assistance in the United States Healthcare reform in the United States Aprepitant Chemotherapy-induced nausea and vomiting Medicare Chemotherapy Cisplatin Medicine Chemistry Organofluorides

UPDATE